0001062993-25-016285.txt : 20251024 0001062993-25-016285.hdr.sgml : 20251024 20251024155226 ACCESSION NUMBER: 0001062993-25-016285 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251024 DATE AS OF CHANGE: 20251024 EFFECTIVENESS DATE: 20251024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eliaz Therapeutics Inc. CENTRAL INDEX KEY: 0002042609 ORGANIZATION NAME: EIN: 475133162 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562048 FILM NUMBER: 251416042 BUSINESS ADDRESS: STREET 1: 398 TESCONI COURT CITY: SANTA ROSA STATE: CA ZIP: 95401 BUSINESS PHONE: 6282664770 MAIL ADDRESS: STREET 1: 398 TESCONI COURT CITY: SANTA ROSA STATE: CA ZIP: 95401 D 1 primary_doc.xml X0708 D LIVE 0002042609 Eliaz Therapeutics Inc. 398 TESCONI COURT SANTA ROSA CA CALIFORNIA 95401 707 542-5856 DELAWARE None None Corporation true Isaac Eliaz 398 TESCONI COURT Santa Rosa CA CALIFORNIA 95401 Executive Officer Director Milton Goss 398 TESCONI COURT Santa Rosa CA CALIFORNIA 95401 Executive Officer Biotechnology Decline to Disclose 06b false 2025-03-28 false true SAFEs false 100000 850000 850000 0 false 4 0 0 50000 A portion of the proceeds may be used to pay executive salaries but would not be deemed compensation for sales under this offering. false Eliaz Therapeutics Inc. /s/ Isaac Eliaz Isaac Eliaz Chief Executive Officer 2025-09-24